Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Integra Accell Evo3 Demineralized Bone Matrix in Instrumented Lumbar Spine Fusion

NCT01714804 is registered in ClinicalTrials.gov with SeaSpine, Inc. as lead sponsor.

NCT NCT01714804
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01714804 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Integra Accell Evo3 Demineralized Bone Matrix in Instrumented Lumbar Spine Fusion
Lead sponsor
SeaSpine, Inc.
Phase
Not applicable
Overall status
Completed
Start date
August 31, 2012
Completion date
October 31, 2016
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

degenerative changes, spondylosis, stenosis